SMGMEDIUM SIGNALFINANCIAL10-K

SMG's operating income substantially improved while cash flow from operations declined meaningfully, suggesting improved profitability but tighter working capital management.

The substantial improvement in operating leverage indicates better cost control or pricing power, which should support margins going forward. However, the decline in operating cash flow alongside reduced cash balances suggests the company may be managing working capital more aggressively or facing collection timing issues that warrant monitoring.

Comparing 2024-11-26 vs 2024-11-26View on EDGAR →
FINANCIAL ANALYSIS

SMG delivered strong profitability improvements with gross profit growing modestly and operating income substantially higher, demonstrating improved operational efficiency. However, operating cash flow declined meaningfully while cash balances dropped by nearly half, indicating potential working capital pressures or timing differences between earnings and cash generation. The increase in stockholders' equity provides a buffer, but the cash flow dynamics suggest investors should monitor liquidity trends closely.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+71.7%
$208.8M$358.6M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Cash & Equivalents
Balance Sheet
-48.9%
$71.6M$36.6M

Cash declined 48.9% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Stockholders Equity
Balance Sheet
+45.3%
$697.2M$1.0B

Equity base grew 45.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Operating Cash Flow
Cash Flow
-44.4%
$667.5M$371.3M

Operating cash flow fell 44.4% — earnings quality concerns; investigate working capital changes and non-cash items.

Gross Profit
P&L
+22.8%
$850.5M$1.0B

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →